U.S. flag

An official website of the United States government

Here’s how you know
Here’s how you know

**Official websites use .gov**
A **.gov** website belongs to an official government organization in the United States.

**Secure .gov websites use HTTPS**
A **lock** ( A locked padlock) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Search Query:
			MAIN MENU

																				
              Health Topics
								All Health Topics A-Z
					
													
		

		Asthma


				

															Heart-Healthy Living


				

															High Blood Pressure


				

															Sickle Cell Disease


				

															Sleep Apnea


				

															Information & Resources on COVID-19
																				
              Health Education
								Education Programs and Initiatives
					
													
		

		The Heart Truth®


				

															Learn More Breathe Better®


				

															Blood Diseases and Disorders Education Program


				

															Publications and Resources
																				
              The Science
								Research Focus Areas
					
													
		

		Blood Disorders and Blood Safety


				

															Sleep Science and Sleep Disorders


				

															Lung Diseases


				

															Health Disparities and Inequities


				

															Heart and Vascular Diseases


				

															Precision Medicine Activities


				

															Obesity, Nutrition, and Physical Activity


				

															Population and Epidemiology Studies


				

															Women’s Health


				

															Research Topics


				

															Clinical Trials


				

															All Science A-Z
																				
              Grants and Training
								Grants and Training Home


				

															Policies and Guidelines


				

															Funding Opportunities and Contacts


				

															Training and Career Development
																				
              News and Events
								News and Events Home
					
													
		

		Email Alerts


				

															All News
					
													
		

		NHLBI News


				

															NHLBI in the Press


				

															Research Features


				

															All Events
					
													
		

		Past Events


				

															Upcoming Events
																				
              About NHLBI
								About NHLBI Home
					
													
		

		Mission and Strategic Vision


				

															Leadership


				

															Divisions, Offices and Centers


				

															Advisory Committees


				

															Budget and Legislative Information


				

															Jobs and Working at the NHLBI


				

															Contact and FAQs


				

															NIH Sleep Research Plan
						
						HOME
		Search Text: Research Topics
  
  Home< Back ToResearch TopicsAnemia Research
  Anemia Research
Language switcherEnglishEspañol
IN THIS ARTICLE
        View More
        View Less
The NHLBI leads and supports research on anemia, a condition that develops when your blood has a lower-than-normal amount of red blood cells or hemoglobin. Our research has helped scientists and doctors better understand the causes of anemia, and we have led and supported projects to discover exciting new treatments for this condition. We continue to fund studies to improve the survival and quality of life of people who have anemia. Research on anemia is part of NHLBI’s broader commitment to advancing scientific discovery for blood disorders and blood safety.

You can also find information on NHLBI-led sickle cell disease research on our website.
More on anemia
      Cartoon image of a clipboard with medical red cross in the middle
      Patient information
              Cartoon image of a microscope
      Find a clinical trial
  NHLBI research that really made a difference

            NHLBI research that really made a difference
      
            **Improving blood safety:** ​​​​​​Since 1989, the Recipient Epidemiology Donor Studies (REDS) program has been the premier research program in blood collection and transfusion safety in the United States. It supports research that will improve donor blood collection and make donor blood safer and available for the treatment of anemia in limited-resource settings.
	**New treatments for aplastic anemia:**NHLBI researchers helped develop treatments for aplastic anemia, a rare but serious blood disorder that occurs when your bone marrow cannot make enough new blood cells for the body to work normally. Aplastic anemia is treated with medicines called immunosuppressants that calm the immune system. However, immunosuppressants do not work well in about one-third of people who have aplastic anemia. To help solve this problem, the NHLBI led studies to show that eltrombopag, a medicine that helps the body make more blood cells, is an effective treatment option for aplastic anemia.

          
Current research funded by the NHLBI

            Current research funded by the NHLBI
      
            Our Division of Blood Diseases and Resources and its Blood Epidemiology and Clinical Therapeutics Branch oversee most of NHLBI’s anemia research.


  RESEARCH FUNDING
      
                    
                    

                                            
            Find funding opportunities and program contacts for anemia research.
      
            **Current research on anemia treatment**

The NHLBI continues to support research to improve anemia treatment.

**Blood and bone marrow studies:** The NHLBI and NCI launched the Blood and Marrow Transplant Clinical Trials Network in 2001. This network promotes large clinical trials to improve blood and bone marrow transplantation, which can cure some types of anemia.
	**Anemia and pregnancy:** The NHLBI funds research to understand the link between anemia during pregnancy and serious complications in preterm newborns, and to develop effective blood transfusion guidelines to treat anemia in these babies.
	**Genetic therapy research:** The NHLBI supports research to develop new treatment options for anemia, such as genetic therapies.Find anemia clinical trials.


  NHLBI IN THE PRESS
      
                    
                    

                                            
            Learn about NHLBI-supported research on treating anemia in preterm newborns in the NHLBI press release, Transfusions with high red blood cell levels do not improve survival, development of preemies.
Find more NHLBI-funded studies on anemia treatment at NIH RePORTER.

**Current research on causes of anemia**

**Red blood cells and anemia:** NHLBI-supported research is helping scientists and doctors understand what causes anemia. For example, we fund projects to better understand how the body makes red blood cells in a healthy person and in a person who has anemia.

**Risk factors for anemia:** Other studies we support are exploring how race and serious health conditions such as obesity, kidney disease, and heart disease affect a person’s risk of anemia.

Find more NHLBI-funded studies on the causes of anemia at NIH RePORTER.

**Supporting anemia research globally**

**Low-cost tests for anemia:** The World Health Organization (WHO) estimates that about 42% of young children and 40% of pregnant women worldwide have anemia. NHLBI-funded studies have helped researchers develop effective low-cost tests to diagnose anemia and improve the safety and availability of donor blood used to treat anemia around the world.

Find more NHLBI-funded international studies on anemia at NIH RePORTER.

          
Anemia research labs at the NHLBI

            Anemia research labs at the NHLBI
      
            Researchers from several NHLBI laboratories on the NIH campus are focused on developing new treatments for anemia, including:

The Hematopoiesis and Bone Marrow Failure Laboratory, within the Hematology Branch
	The Molecular Hematopoiesis Laboratory within the Translational Stem Cell Biology Branch
	The Regenerative Therapies for Inherited Blood Disorders Laboratory, and the Transplantation Immunotherapy Laboratory, within the Cellular and Molecular Therapeutics BranchResearchers in these labs study how the body makes blood cells and how the immune system contributes to anemia. Our researchers are also working on developing genetic therapies and other new options to treat anemia. Read more about these projects and ongoing clinical trials.


  RESEARCH FEATURE
      
                    
                    

                                            
            Read about how eltrombopag helped cure one patient’s aplastic anemia.

Tenacity Topples Transfusion: How One Woman’s Determination Helped Her Defeat a Devastating Blood Disease.

          
Related anemia programs

            Related anemia programs
      
            NHLBI has multiple research programs to ensure the adequacy and safety of the Nation's blood supply, and to support efforts to treat and cure blood disorders.

The NHLBI’s Recipient Epidemiology and Donor Evaluation Study (REDS) program began in 1989 to protect the Nation’s blood supply and improve the benefits and reduce the risks of transfusions. Now in its fourth phase, called REDS-IV, the program supports research in the United States and around the world, with a new focus on previously understudied populations.
	The Biologic Specimen and Data Repository Information Coordinating Center (BioLINCC) provides a centralized system to manage biospecimens and clinical data that were once stored in separate repositories. Researchers can find and request available resources on BioLINCC’s secure website.
  Explore more NHLBI research on anemia

            The sections above provide you with the highlights of NHLBI-supported research on anemia. You can explore the full list of NHLBI-funded studies on the NIH RePORTER.
      
            To find more studies:

Type your search words into the Quick Search box and press enter.
	Check Active Projects if you want current research.
	Select the Agencies arrow, then the NIH arrow, then check NHLBI.If you want to sort the projects by budget size — from the biggest to the smallest — click on the FY Total Cost by IC column heading.
  Last updated on March 24, 2022 Back To Top Link
  

        

        Back to top
  Web Policies & Notices
  

        

              Accessibility
                      No FEAR Act Data
                      Privacy Policy
                      Freedom of Information Act (FOIA)
                      HHS Vulnerability Disclosure
    
          Related Government Websites
  

        

              Health and Human Services
                      National Institutes of Health
                      Office of the Inspector General
                      USA.gov
    
          Stay Connected
    
      
            chat bubblesLive ChatLive Chat with us, Monday through Friday, 8:30 a.m. to 5:00 p.m. EST.envelopeGet Email AlertsReceive automatic alerts about NHLBI related news and highlights from across the Institute.
  Footer Bottom
  

        



Contact Us
                            Site Index
                            Jobs